Pancreatic Cancer Research

ResearcherPusan National UniversityActive in the last 2 years

Hyung Il Seo

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4132-7662; OpenAlex author ID A5075959128, A5155936136. Sources: OpenAlex.

Their work

Papers
6 (first author 2, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
42
Papers, trials and grants by year

2020: 2 papers · 2021: none · 2022: none · 2023: 1 paper · 2024: none · 2025: none · 2026: 3 papers

Papers 6

  1. International multicenter validation of an 18F-fluorodeoxyglucose positron emission tomography/computed tomography maximum standardized uptake value 4.0 thresh… Co-author DOI 10.1016/j.surg.2026.110503↗
  2. Efficacy of neoadjuvant FOLFIRINOX in resectable pancreatic cancer (NeoFOL-R): study protocol for an international, multicenter, prospective, randomized contro… Co-author DOI 10.1186/s12885-026-15639-6↗
  3. Low prealbumin predicts early recurrence after pancreatic cancer surgery: a retrospective cohort study. First author DOI 10.21037/gs-2026-0156↗
  4. Clinical significance of C-reactive protein-to-prealbumin ratio in predicting early recurrence in resectable pancreatic cancer. First author DOI 10.14216/kjco.23003↗
  5. Comparison of gemcitabine plus nab-paclitaxel and FOLFIRINOX in metastatic pancreatic cancer. Last author DOI 10.12998/wjcc.v8.i17.3718↗
  6. First-line chemotherapy in very elderly patients with metastatic pancreatic cancer: Gemcitabine monotherapy vs combination chemotherapy. Last author DOI 10.12998/wjcc.v8.i18.4022↗

Closest collaborators

The 25 strongest of 42 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Seung Baek Hong · 4 shared papers, 2020–2026 · strength 0.70
  2. Nam Kyung Lee · 4 shared papers, 2020–2026 · strength 0.70
  3. Byeong Gwan Noh · 2 shared papers, 2023–2026 · strength 0.45
  4. Sung Yong Han · 3 shared papers, 2020–2023 · strength 0.43
  5. Dong Uk Kim · 3 shared papers, 2020–2023 · strength 0.43
  6. Yoo‐Seok Yoon · 2 shared papers, 2026 · strength 0.38
  7. Wooil Kwon · 2 shared papers, 2026 · strength 0.38
  8. Byung Soo Park · 1 shared paper, 2026 · strength 0.27
  9. Myeong Hun Oh · 1 shared paper, 2026 · strength 0.27
  10. Isamu Makino · 1 shared paper, 2026 · strength 0.19
  11. Atsushi Tomioka · 1 shared paper, 2026 · strength 0.19
  12. Teiichi Sugiura · 1 shared paper, 2026 · strength 0.19
  13. Shintaro Yagi · 1 shared paper, 2026 · strength 0.19
  14. Tetsuya Idichi · 1 shared paper, 2026 · strength 0.19
  15. Kousei Ishigami · 1 shared paper, 2026 · strength 0.19
  16. Hongbeom Kim · 1 shared paper, 2026 · strength 0.19
  17. Shigeru Marubashi · 1 shared paper, 2026 · strength 0.19
  18. Naru Kim · 1 shared paper, 2026 · strength 0.19
  19. Minoru Oshima · 1 shared paper, 2026 · strength 0.19
  20. Munseok Choi · 1 shared paper, 2026 · strength 0.19
  21. Masayuki Tanaka · 1 shared paper, 2026 · strength 0.19
  22. Katsuhisa Ohgi · 1 shared paper, 2026 · strength 0.19
  23. Yoon Soo Chae · 1 shared paper, 2026 · strength 0.19
  24. Etsuro Hatano · 1 shared paper, 2026 · strength 0.19
  25. Shingo Baba · 1 shared paper, 2026 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.